Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 9/20 | 0.46 |
| ▸ | MEN1 | O00255 | 8/20 | 0.46 |
| ▸ | MAPT | P10636 | 7/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | IDE | P14735 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13619055 | 0.86 | IDO1 (0.46) | KMT2AMEN1MAPTALDH1A1CYP1A2 | |
| SCHEMBL12906940 | 0.84 | MAPT (0.44) | KMT2AMEN1MAPTTRPA1ALDH1A1 | |
| SCHEMBL13387405 | 0.78 | TRPA1 (0.48) | KMT2AMEN1MAPTTRPA1ALDH1A1 | |
| SCHEMBL13793185 | 0.78 | PHLPP2 (0.55) | KMT2AMEN1MAPTALDH1A1CYP1A2 | |
| SCHEMBL28412805 | 0.75 | MAPT (0.48) | KMT2AMEN1MAPTALDH1A1CYP1A2 | |
| SCHEMBL14134313 | 0.75 | TRPA1 (0.53) | KMT2AMEN1MAPTTRPA1ALDH1A1 | |
| Azobenzene SCHEMBL29009080 | 0.72 | ALDH1A1 (0.70) | KMT2AMEN1MAPTTRPA1ALDH1A1 | |
| SCHEMBL22256322 | 0.72 | MEN1 (0.59) | KMT2AMEN1MAPTTRPA1ALDH1A1 | |
| SCHEMBL22256323 | 0.72 | MEN1 (0.59) | KMT2AMEN1MAPTTRPA1ALDH1A1 | |
| SCHEMBL13065577 | 0.72 | MEN1 (0.51) | KMT2AMEN1MAPTTRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619074-B2 | Reactive dyestuff with N,N-dialkylamino bridge group | EVERLIGHT USA, INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-20090176972-A1 | Novel reactive dyestuff with N,N-dialkylamino bridge group | EVERLIGHT USA, INC. (US) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176972-A1 | Novel reactive dyestuff with N,N-dialkylamino bridge group | SRM, PADI1, NOS1 | KMT2A 237/4885MEN1 1375/4885MAPT 940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.